Jan 25, 2025, 04:58
Al-Ola Abdallah: Myeloma Drug Prices
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on X about a recent paper by Praneeth Reddy Keesari et al. published in Current Hematologic Malignancy Reports:
“Myeloma Drug Prices (from the expensive to the cheapest!)
- Cilta-Cel $507,000
- Ide-Cel $503,000
- Elrantamab $486,000/yr
- Selinexor $442,000/yr
- Talquetamab $372,000/yr
- Pomalidomide $300,000/yr
- Lenalidomide $240,000/yr
- Teclistimab $235,000/yr
- Carfilzomib $173,000/yr
- Daratumumab $165,000/yr
- Ixazomib $136,000/yr
- Cyclophosphamide $8,000/yr
- Bortezomib $2,000/yr
- Dexamethasone $570/yr.”
Authors: Praneeth Reddy Keesari, Diana Samuels, Charan Thej Reddy Vegivinti, Yashwitha Sai Pulakurthi, Revathi Kudithi, Meekoo Dhar, Murali Janakiram.
More posts featuring Al-Ola Abdallah.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 25, 2025, 04:58
Jan 25, 2025, 04:25
Jan 25, 2025, 04:17
Jan 25, 2025, 03:52
Jan 25, 2025, 03:50
Jan 25, 2025, 03:44
Jan 25, 2025, 03:43